Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Ciclopirox Patent Expiration

Ciclopirox is Used for treating interdigital tinea pedis and tinea corporis caused by certain types of fungi. It was first introduced by Medimetriks Pharmaceuticals Inc in its drug Loprox on Dec 30, 1982. Other drugs containing Ciclopirox are Penlac, Ciclopirox. 21 different companies have introduced drugs containing Ciclopirox.


Ciclopirox Patents

Given below is the list of patents protecting Ciclopirox, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Ciclopirox US7018656 Antimycotic gel with high active substance release Sep 05, 2018

(Expired)

 Alvogen
Loprox US7981909 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis Sep 16, 2017

(Expired)

 Bausch
Loprox US8227490 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis Sep 16, 2017

(Expired)

 Bausch
Ciclopirox US7026337 Antimycotic gel having high active compound release Nov 21, 2016

(Expired)

 Alvogen



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Ciclopirox's patents.

Given below is the list recent legal activities going on the following patents of Ciclopirox.

Activity Date Patent Number
Patent litigations
Expire Patent
Critical
 07 May, 2018 US7026337
Maintenance Fee Reminder Mailed
Critical
 20 Nov, 2017 US7026337
Change in Power of Attorney (May Include Associate POA)
Critical
 27 Mar, 2009 US7026337
Correspondence Address Change
Critical
 24 Mar, 2009 US7026337
Change in Power of Attorney (May Include Associate POA)
Critical
 18 Sep, 2007 US7026337
Recordation of Patent Grant Mailed
Critical
 11 Apr, 2006 US7026337
Patent Issue Date Used in PTA Calculation
Critical
 11 Apr, 2006 US7026337
Issue Notification Mailed
Critical
 22 Mar, 2006 US7026337
Dispatch to FDC 09 Mar, 2006 US7026337
Application Is Considered Ready for Issue
Critical
 27 Jan, 2006 US7026337


Ciclopirox's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ciclopirox Generic API Manufacturers

Several generic applications have been filed for Ciclopirox. The first generic version for Ciclopirox was by Fougera Pharmaceuticals Inc and was approved on Aug 6, 2004. And the latest generic version is by Encube Ethicals Private Ltd and was approved on Apr 5, 2018.

Given below is the list of companies who have filed for Ciclopirox generic, along with the locations of their manufacturing plants worldwide.


1. ACELLA

Acella Pharmaceuticals Llc has filed for 1 generic for Ciclopirox. Given below are the details of the strengths of this generic introduced by Acella.

Strength Dosage Form Availability Application Pathway TE code Launch Date
8%

solution Prescription TOPICAL AT Sep 18, 2007


Manufacturing Plant Locations
New

Acella's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Acella as present at those locations.

Country City Firm Name
United States
Alpharetta Acella Pharmaceuticals, LLC





2. ACTAVIS MID ATLANTIC

Actavis Mid Atlantic Llc has filed for 1 generic for Ciclopirox. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1%

shampoo Prescription TOPICAL AT Nov 24, 2009





3. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 1 generic for Ciclopirox. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
8%

solution Prescription TOPICAL AT Sep 18, 2007





4. COSETTE

Cosette Pharmaceuticals Inc has filed for 2 different strengths of generic version for Ciclopirox. Given below are the details of the strengths of this generic introduced by Cosette.

Strength Dosage Form Availability Application Pathway TE code Launch Date
8%

solution Discontinued TOPICAL N/A Sep 18, 2007
0.77%

cream Prescription TOPICAL AB Dec 20, 2010


Manufacturing Plant Locations
New

Cosette's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cosette as present at those locations.

Country City Firm Name
United States
Lincolnton Cosette Pharmaceuticals NC Laboratories, LLC
South Plainfield Cosette Pharmaceuticals, Inc.





5. ENCUBE

Encube Ethicals Private Ltd has filed for 2 different strengths of generic version for Ciclopirox. Given below are the details of the strengths of this generic introduced by Encube.

Strength Dosage Form Availability Application Pathway TE code Launch Date
8%

solution Prescription TOPICAL AT Sep 18, 2007
1%

shampoo Discontinued TOPICAL N/A Apr 5, 2018


Manufacturing Plant Locations
New

Encube's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Encube as present at those locations.

Country City Firm Name
India
Andheri East, Mumbai Encube Ethicals Private Ltd
Ponda Encube Ethicals Pvt. Ltd.





6. EPIC PHARMA LLC

Epic Pharma Llc has filed for 1 generic for Ciclopirox. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
8%

solution Discontinued TOPICAL N/A Feb 17, 2010





7. FOUGERA PHARMS

Fougera Pharmaceuticals Inc has filed for 2 different strengths of generic version for Ciclopirox. Given below are the details of the strengths of this generic introduced by Fougera Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.77%

gel Prescription TOPICAL AB Jun 10, 2008
1%

shampoo Prescription TOPICAL AT May 25, 2010





8. GLENMARK PHARMS

Glenmark Pharmaceuticals Inc Usa has filed for 1 generic for Ciclopirox. Given below are the details of the strengths of this generic introduced by Glenmark Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.77%

cream Prescription TOPICAL AB Nov 10, 2009





9. GLENMARK PHARMS INC

Glenmark Pharmaceuticals Inc Usa has filed for 1 generic for Ciclopirox. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.77%

(reference standard)

gel Prescription TOPICAL AB Feb 29, 2012





10. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Ciclopirox. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
8%

solution Discontinued TOPICAL N/A Sep 18, 2007


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Cherry Hill Hikma Pharmaceuticals USA Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Dayton Hikma Injectables USA Inc
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





11. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 1 generic for Ciclopirox. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
8%

solution Discontinued TOPICAL N/A Sep 18, 2007





12. PADAGIS ISRAEL

Padagis Israel Pharmaceuticals Ltd has filed for 1 generic for Ciclopirox. Given below are the details of the strengths of this generic introduced by Padagis Israel.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.77%

suspension Prescription TOPICAL AB Dec 15, 2006


Manufacturing Plant Locations
New

Padagis Israel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Padagis Israel as present at those locations.

Country City Firm Name
Israel
Yerucham Padagis Israel Pharmaceuticals Ltd.





13. PADAGIS US

Padagis Us Llc has filed for 3 different strengths of generic version for Ciclopirox. Given below are the details of the strengths of this generic introduced by Padagis Us.

Strength Dosage Form Availability Application Pathway TE code Launch Date
8%

(reference standard)

solution Prescription TOPICAL AT Sep 18, 2007
0.77%

gel Prescription TOPICAL AB Jan 7, 2009
1%

shampoo Prescription TOPICAL AT Feb 16, 2010


Manufacturing Plant Locations
New

Padagis Us's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Padagis Us as present at those locations.

Country City Firm Name
United States
Minneapolis Padagis US LLC





14. RISING

Rising Pharma Holdings Inc has filed for 1 generic for Ciclopirox. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
8%

solution Prescription TOPICAL AT Sep 18, 2007


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Saddle Brook Rising Pharmaceuticals, Inc.
Mount Morris Rising Creek Bakery LLC
Livingston Risingsun Iodine Products Corp.
Decatur Rising Pharma Holdings, Inc
Fort Bragg Rising Tide Sea Vegetables
East Brunswick Rising Pharma Holding, Inc.
Rising Sun Rising Sun Veterinary Clinic
Phoenix Rising Sun Farms Inc
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





15. TARO

Taro Pharmaceuticals Inc has filed for 2 different strengths of generic version for Ciclopirox. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.77%

suspension Prescription TOPICAL AB Aug 10, 2005
1%

shampoo Prescription TOPICAL AT Feb 23, 2011


Manufacturing Plant Locations
New

Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.

Country City Firm Name
United States
Hawthorne Taro Pharmaceuticals U.S.A., Inc.
Honolulu Taro Delight, LLC
Israel
Haifa Taro Pharmaceutical Industries, Ltd.
Canada
Brampton Taro Pharmaceuticals Inc.





16. TARO PHARM INDS

Taro Pharmaceutical Industries Ltd has filed for 1 generic for Ciclopirox. Given below are the details of the strengths of this generic introduced by Taro Pharm Inds.

Strength Dosage Form Availability Application Pathway TE code Launch Date
8%

solution Prescription TOPICAL AT Sep 18, 2007





17. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 1 generic for Ciclopirox. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
8%

solution Discontinued TOPICAL N/A Sep 18, 2007